Foresight Global Investors Inc. Acquires 19,739 Shares of Nutrien Ltd. (NYSE:NTR)

Foresight Global Investors Inc. lifted its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 164.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 31,739 shares of the company’s stock after buying an additional 19,739 shares during the period. Nutrien makes up approximately 1.0% of Foresight Global Investors Inc.’s portfolio, making the stock its 11th largest position. Foresight Global Investors Inc.’s holdings in Nutrien were worth $1,420,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Uncommon Cents Investing LLC lifted its position in shares of Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock worth $517,000 after acquiring an additional 235 shares during the period. Rhumbline Advisers raised its stake in shares of Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock valued at $331,000 after purchasing an additional 247 shares in the last quarter. FFT Wealth Management LLC raised its stake in shares of Nutrien by 0.9% in the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company’s stock valued at $1,330,000 after purchasing an additional 277 shares in the last quarter. Atria Investments Inc lifted its position in Nutrien by 2.0% in the third quarter. Atria Investments Inc now owns 14,636 shares of the company’s stock worth $703,000 after purchasing an additional 290 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in Nutrien by 23.9% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company’s stock worth $81,000 after buying an additional 348 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Trading Down 0.2 %

NTR opened at $52.06 on Wednesday. Nutrien Ltd. has a 1-year low of $43.70 and a 1-year high of $60.87. The firm has a 50-day moving average price of $51.41 and a two-hundred day moving average price of $48.74. The stock has a market capitalization of $25.47 billion, a PE ratio of 38.00, a PEG ratio of 1.19 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38.

Nutrien (NYSE:NTR) last posted its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. As a group, equities analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 4.19%. The ex-dividend date is Monday, March 31st. Nutrien’s dividend payout ratio (DPR) is presently 159.12%.

Analysts Set New Price Targets

NTR has been the subject of a number of recent research reports. Scotiabank raised their price objective on shares of Nutrien from $60.00 to $62.00 and gave the stock a “sector outperform” rating in a report on Monday, February 24th. Oppenheimer started coverage on shares of Nutrien in a research report on Thursday, December 12th. They issued an “outperform” rating and a $60.00 price target for the company. Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $58.00 to $60.00 in a report on Tuesday, December 3rd. Royal Bank of Canada reissued an “outperform” rating and issued a $60.00 target price on shares of Nutrien in a report on Monday, February 24th. Finally, The Goldman Sachs Group started coverage on Nutrien in a research note on Thursday, March 13th. They issued a “sell” rating and a $53.00 price target on the stock. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, Nutrien currently has an average rating of “Hold” and a consensus target price of $60.13.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.